Patents by Inventor Chunjie SHA

Chunjie SHA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE REGIMEN OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION
    Publication number: 20230248732
    Abstract: Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 10, 2023
    Inventors: Youxin LI, Chunjie SHA, Fengjuan ZHAO, Changbing TU, Kaoxiang SUN, Wanhui LIU, Lifang SUN, Ying MENG
  • Dosage regimen of paliperidone palmitate extended-release injectable suspension
    Patent number: 11666573
    Abstract: Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: June 6, 2023
    Assignee: Geneora Pharma (Shijiazhuang) Co., Ltd.
    Inventors: Youxin Li, Chunjie Sha, Fengjuan Zhao, Changbing Tu, Kaoxiang Sun, Wanhui Liu, Lifang Sun, Ying Meng
  • Rotigotine behenate, and manufacturing method and application thereof
    Patent number: 11111227
    Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: September 7, 2021
    Assignee: Shandong Luye Pharmaceutical Co., Ltd.
    Inventors: Mina Yang, Yongtao Jiang, Ying Meng, Tao Wang, Qian qian Xu, Xin Shao, Chunjie Sha
  • DOSAGE REGIMEN OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION
    Publication number: 20200297729
    Abstract: Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.
    Type: Application
    Filed: October 26, 2018
    Publication date: September 24, 2020
    Inventors: Youxin LI, Chunjie SHA, Fengjuan ZHAO, Changbing TU, Kaoxiang SUN, Wanhui LIU, Lifang SUN, Ying MENG
  • ROTIGOTINE BEHENATE, AND MANUFACTURING METHOD AND APPLICATION THEREOF
    Publication number: 20200255396
    Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 13, 2020
    Inventors: Mina YANG, Yongtao JIANG, Ying MENG, Tao WANG, Qian qian XU, Xin SHAO, Chunjie SHA
  • Rotigotine behenate, and manufacturing method and application thereof
    Patent number: 10669249
    Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: June 2, 2020
    Assignee: Shandong Luye Pharmaceutical Co., Ltd.
    Inventors: Mina Yang, Yongtao Jiang, Ying Meng, Tao Wang, Qian qian Xu, Xin Shao, Chunjie Sha
  • ROTIGOTINE BEHENATE, AND MANUFACTURING METHOD AND APPLICATION THEREOF
    Publication number: 20190330177
    Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.
    Type: Application
    Filed: July 21, 2016
    Publication date: October 31, 2019
    Inventors: Mina YANG, Yongtao JIANG, Ying MENG, Tao WANG, Qian qian XU, Xin SHAO, Chunjie SHA